All coins

WiremarketsDextape brief

3M To Pay $7,350,000,000 To Settle Injury Claims Over ‘Forever Chemicals’ in Firefighting Foam

Manufacturing giant 3M has agreed to pay billions of dollars to resolve most of the personal injury claims tied to “forever chemicals” in firefighting foam. The company says it will make a $7.35 billion commitment over nine years, with a present value of $5.

Dextape brief

By Dextape Desk ·

Manufacturer 3M has agreed to resolve most personal injury claims tied to PFAS, so-called forever chemicals used in firefighting foam that persist in the environment and have been linked to cancer, according to The Hill. The company says it will pay $7.35 billion over nine years, worth $5.8 billion in present value, within the AFFF litigation before a South Carolina federal court. The settlement covers about 99% of current injury claims inside and outside that litigation, involving roughly 115,000 to 120,000 eligible plaintiffs. Payments begin in 2026 at $50 million, with none scheduled for 2027, and a $680 million reserve addresses remaining and future claims. 3M denies liability, and its CEO, William Brown, called it a significant milestone.

Why it matters: It shows how litigation tied to persistent chemicals can reach billions of dollars, a sign of the scale of legal exposure large companies can face.

Summary by Dextape, based on reporting by DailyHodl. Written with AI from the publisher’s text and checked automatically for copied wording and unsupported figures. Not investment advice.

Read the full story

Headline and excerpt from DailyHodl’s public feed. DailyHodl holds the copyright and publishes the full story; Dextape links to it rather than reprinting it.

Mentioned in this story

Open a coin page for its current price.

Brief by

Dextape DeskEditors

The Dextape Desk signs Dextape's own work: briefs on wire stories, the daily market report and desk analysis. Briefs are written by an AI model from the publisher's article text and checked automatically for copied wording, unsupported figures and investment advice before they appear. AI drafts from the editorial desk need corroborating sources and an editor's review before release.

Share this story